Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 1, 2015, Pages 1-9

  Alshatwi, Ali A ^a   Athinarayanan, Jegan ^a   Vaiyapuri Subbarayan, Periasamy ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CRYSTALLINE MATERIALS; CYTOLOGY; DISEASES; DRUG DOSAGE; DRUG INTERACTIONS; MORPHOLOGY; NANOPARTICLES; PLATINUM; PLATINUM COMPOUNDS; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CERVICAL CANCER TREATMENT; CHEMOTHERAPEUTIC DRUGS; CHROMATIN CONDENSATION; FACE CENTERED CUBIC STRUCTURE; FUNCTIONALIZED NANOPARTICLES; NUCLEAR FRAGMENTATION; PLATINUM NANO-PARTICLES; SURFACE MODIFYING AGENT;

CELLS;

EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GOLD; HYDROGEN PEROXIDE; IRON; NICOTINAMIDE ADENINE DINUCLEOTIDE; PALLADIUM; PLATINUM NANOPARTICLE; POLYPHENOL; PROPIDIUM IODIDE; SATRAPLATIN; SILVER; SUPEROXIDE; ANTINEOPLASTIC AGENT; METAL NANOPARTICLE; PLATINUM;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CELLULAR STRESS RESPONSE; CERVICAL CANCER CELL LINE; CHROMATIN CONDENSATION; CYTOTOXICITY; DNA FRAGMENTATION; ENVIRONMENTAL TEMPERATURE; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GREEN CHEMISTRY; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MTT ASSAY; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; UTERINE CERVIX CANCER; X RAY DIFFRACTION; CELL CYCLE G2 PHASE; CELL DIVISION; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; FEMALE; G2 PHASE; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PLATINUM; UTERINE CERVICAL NEOPLASMS; X-RAY DIFFRACTION;

EID: 84983585716     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5330-1     Document Type: Article

References (56)

1. Jee J, Na JH, Lee S, Kim SH, Choi K, Yeo Y, Kwon IC. Cancer targeting strategies in nanomedicine: design and application of chitosan nanoparticles. Curr Opin Solid State Mater Sci. 2012;16:333–42.
2. Rosenholm JM, Sahlgren C, Lindén M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles–opportunities & challenges. Nanoscale. 2010;2:1870–83.
3. Bourzac K. Nanotechnology: carrying drugs. Nature. 2012;491:S58–60.
4. Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis (Review). Mol Membr Biol. 2010;27:274–85.
5. Pescatori M, Davide B, Enrica V, Cécili M, Camilla B, Elena M, Andrea P, et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials. 2013;34:4395–403.
6. Delogu LG, Enrica V, Roberto M, Gérard AP, Ciriaco C, Roberto M, Luciano M, Francesco S, et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine. 2012;7:231–43.
7. Stephens IEL, Bondarenko AS, Grønbjerg U, Rossmeisl J, Chorkendorff I. Understanding the electrocatalysis of oxygen reduction on platinum and its alloys. Energy Environ Sci. 2012;5:6744–62.
8. Kostova I. Platinum complexes as anticancer agents. Recent Pat Anti-Cancer Drug Discov. 2006;1:1–22.
9. Cowley A. On the use of platinum in biomedical applications. In: The 4th International Platinum Conference, Platinum in transition Boom or Bust, The Southern African Institute of Mining and Metallurgy, 2010.
10. Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104:293–346.
11. Cuenya BR. Synthesis and catalytic properties of metal nanoparticles: size, shape, support, composition, and oxidation state effects. Thin Solid Films. 2010;518:3127–50.
12. Kelly KL, Coronado E, Zhao LL, Schatz GC. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem B. 2003;107:668–77.
13. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium escherichia coli. Appl Environ Microbiol. 2007;73:1712–20.
14. Park S, Xie Y, Weaver MJ. Electrocatalytic pathways on carbon-supported platinum nanoparticles: comparison of particle-size-dependent rates of methanol, formic acid, and formaldehyde electrooxidation. Langmuir. 2002;18:5792–8.
15. Bendale Y, Bendale V, Paul S, Bhattacharyya SS. Green synthesis, characterization and anticancer potential of platinum nanoparticles bioplatin. Chin J integr med. 2012;10:681–9.
16. Endo K, Ueno T, Kondo S, Wakisaka N, Murono S, Ito M, Kataoka K, Kato Y, Yoshizaki T. Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma. Cancer Sci. 2013;104:369–74.
17. Hou J, Shang J, Jiao C, Jiang P, Xiao H, Luo L, Liu T. A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency. Macromol Biosci. 2013;13:954–65.
18. Min Y, Li J, Liu F, Yeow EK, Xing B. NIR light mediated photoactivation pt based antitumor prodrug and simultanous cellular apoptosis imaging via upconversion nanoparticles. Angew Chem Int Ed Engl. 2014;53:1012–6.
19. Mironava T, Simon M, Rafailovich MH, Rigas B. Platinum folate nanoparticles toxicity: cancer vs. normal cells. Toxicol In Vitro. 2013;27:882–9.
20. Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, et al. Sequential application of a cytotoxic nanoparticle and a PI3 K inhibitor enhances antitumor efficacy. Cancer Res. 2014;74:675–85.
21. Rout SR, Behera B, Maiti TK, Mohapatra S. Multifunctional magnetic calcium phosphate nanoparticles for targeted platin delivery. Dalton Trans. 2012;41:10777–83.
22. Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, et al. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc Natl Acad Sci U S A. 2012;109:11294–9.
23. Wang J, Wang X, Song Y, Zhu C, Wang K, Guo Z. Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles. Chem Commun (Camb). 2013;49:2786–8.
24. Yang J, Sun X, Mao W, Sui M, Tang J, Shen Y. Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy. Mol Pharm. 2012;9:2793–800.
25. Yoshihisa Y, Zhao QL, Hassan MA, Wei ZL, Furuichi M, Miyamoto Y, Kondo T, Shimizu T. SOD/catalase mimetic platinum nanoparticles inhibit heat-induced apoptosis in human lymphoma U937 and HH cells. Free Radic Res. 2011;45:326–35.
26. Hikosaka K, Kim J, Kajita M, Kanayama A, Miyamoto Y. Platinum nanoparticles have an activity similar to mitochondrial NADH: ubiquinone oxidoreductase. Colloids Surf B. 2008;66:195–200.
27. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res. 2007;41:615–26.
28. Nellore J, Pauline C, Amarnath K. Bacopa monnieri phytochemicals mediated synthesis of platinum nanoparticles and its neurorescue effect on 1-methyl 4-phenyl 1, 2, 3, 6 tetrahydropyridine-induced experimental parkinsonism in zebrafish. J Neurodegener Disord. 2013;2013:972391.
29. Porcel E, Liehn S, Remita H, Usami N, Koayashi K, Furusawa Y, Lesech C, Lacombe S. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology. 2010;21:085103–10.
30. Manikandan M, Hasan N, Wu HF. Platinum nanoparticles for the photothermal treatment of Neuro 2A cancer cells. Biomaterials. 2013;34:5833–42.
31. Wang S, Meckling KA, Marcone MF, Kakuda Y, Tsao R. Can phytochemical antioxidant rich foods act as anti-cancer agents? Food Res Int. 2011;44:2545–54.
32. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134:3479S–85S.
33. Marchand L, Murphy S, Hankin JH, Wikens LR, Kolonel LN. Intake of flavonoids and lung cancer. J Natl Cancer Inst. 2000;92:154–60.
34. Sun J, Liu RH. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006;241:124–34.
35. Lee YJ, Lee YJ, Im JH, Won SY, Kim YB, Cho MK, Nam HS, Choi YJ, Lee SH. Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells. Food Chem Toxicol. 2013;52:61–8.
36. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89.
37. Periasamy VS, Alshatwi AA. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell. Basic Clin Pharmacol Toxicol. 2013;112:374–84.
38. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005;55:74–108.
39. World d Health Organization (WHO)/InstitutCatalàd’Oncologia (ICO). Summary report. 3rd ed. London: WHO/ICO Information Centre; 2010.
40. Blagosklonny MV, El-Deiry WS. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. Int J Cancer. 1996;67:386–92.
41. Mohanpuria P, Rana NK, Yadav SK. Biosynthesis of nanoparticles: technological concepts and future applications. J Nanopart Res. 2008;10:507–17.
42. Asmathunisha N, Kathiresan K. A review on biosynthesis of nanoparticles by marine organisms. Colloids Surf B. 2013;103:283–7.
43. Kim EY, Ham SK, Shigenaga MK, Han O. Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J Nutr. 2008;138:1647–51.
44. Nadagouda MN, Varma RS. Green synthesis of silver and palladium nanoparticles at room temperature using coffee and tea extract. Green Chem. 2008;10:859–62.
45. Moulton MC, Braydich-Stolle LK, Nadagouda MN, Kunzelman S, Hussain SM, Varma RS. Synthesis, characterization and biocompatibility of “green” synthesized silver nanoparticles using tea polyphenols. Nanoscale. 2010;2:763–70.
46. Venu R, Ramulu TS, Anandakumar S, Rani VS, Kim CG. Bio-directed synthesis of platinum nanoparticles using aqueous honey solutions and their catalytic applications. Colloid Surf A. 2011;384:733–8.
47. Ray PC. Size and shape dependent second order nonlinear optical properties of nanomaterials and their application in biological and chemical sensing. Chem Rev. 2010;110:5332–65.
48. Jensen TR, Malinsky MD, Haynes CL, Van Duyne RP. Nanosphere lithography: tunable localized surface plasmon resonance spectra of silver nanoparticles. J Phys Chem B. 2000;104:10549–56.
49. Smitha SL, Nissamudeen KM, Philip D, Gopchandra KG. Studies on surface plasmon resonance and photoluminescence of silver nanoparticles. Spectrochim Acta A.Mol Biomol Spectrosc. 2008;71:186.
50. Kalimutho M, Minutolo A, Grelli S, Formosa A, Sancesario G, Valentini A, Federici G, Bernardini S. Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance. Cancer Chemother Pharmacol. 2011;67:1299–312.
51. Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. 2010;17:356–62.
52. Ahmed K, Wei Z, Zhao Q, Nakajima N, Matsunaga T, Ogasawara M, Kondo T. Role of fatty acid chain length on the induction of apoptosis by newly synthesized catechin derivatives. Chem Biol Interact. 2010;185:182–8.
53. Alshatwi AA. Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis. J Exp Clin Cancer Res. 2011;29:167–76.
54. Shingu T, Chumbalkar VC, Gwak HS, Fujiwara K, Kondo S, Farrell NP, Bogler O. The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells. Neuro-oncology. 2010;12:1269–77.
55. Passalaris TM, Benanti JA, Gewin L, Kiyono T, Galloway DA. The G2 checkpoint is maintained by redundant pathways. Mol Cell Biol. 1999;19:5872–81.
56. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 1990;82:749–55.